Clover Health Investments Corp
NASDAQ:CLOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clover Health Investments Corp
NASDAQ:CLOV
|
US |
|
Gaussin SA
PAR:ALGAU
|
FR |
|
G
|
Giglio.Com SpA
MIL:GCOM
|
IT |
|
Spire Global Inc
NYSE:SPIR
|
US |
|
Barratt Developments P L C
LSE:BDEV
|
UK |
|
Prosus NV
AEX:PRX
|
NL |
|
Cantaloupe Inc
NASDAQ:CTLP
|
US |
|
S
|
Swedish Match AB
F:SWMC
|
SE |
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
S
|
Sasol Ltd
JSE:SOL
|
ZA |
|
S
|
Starflex PCL
SET:SFLEX
|
TH |
|
S
|
Snam SpA
F:SNM
|
IT |
|
G
|
Globant SA
F:2G2
|
LU |
|
Symbotic Inc
NASDAQ:SYM
|
US |
|
I
|
Impala Platinum Holdings Ltd
JSE:IMP
|
ZA |
|
I
|
ITV PLC
F:IJ7
|
UK |
|
S
|
Synopsys Inc
XMUN:SYP
|
US |
|
Wacker Neuson SE
F:WAC
|
DE |
Wall St Price Targets
CLOV Price Targets Summary
Clover Health Investments Corp
According to Wall Street analysts, the average 1-year price target for
CLOV is 2.6 USD with a low forecast of 1.77 USD and a high forecast of 3.36 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLOV's stock price target?
Price Target
2.6
USD
According to Wall Street analysts, the average 1-year price target for
CLOV is 2.6 USD with a low forecast of 1.77 USD and a high forecast of 3.36 USD.
What is the Revenue forecast for Clover Health Investments Corp?
Projected CAGR
21%
The compound annual growth rate for Revenue over the next 5 years is 21%.